GreenPlex Services, Inc. (GRPX)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
GreenPlex Services, Inc. (GRPX) with AI Score 46/100 (Weak). GreenPlex Services, Inc. operates a cannabis testing laboratory in Washington, focusing on testing cannabis and related products for growers and processors. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 18, 2026GreenPlex Services, Inc. (GRPX) Industrial Operations Profile
GreenPlex Services, Inc., established in 2009, provides essential cannabis testing services in Washington, catering to growers and processors. Operating within the Industrials sector, the company ensures product compliance and safety, distinguishing itself through specialized laboratory services in a regulated market.
Investment Thesis
GreenPlex Services, Inc. presents a focused investment opportunity within the cannabis testing sector. The company's revenue is tied directly to the volume of cannabis production and processing in Washington, making it sensitive to regulatory changes and market dynamics. Key value drivers include maintaining accreditation and expanding testing capabilities to meet evolving standards. Growth catalysts involve securing contracts with larger producers and expanding service offerings to include new testing methodologies. Potential risks include increased competition from other testing labs and changes in state regulations that could impact testing requirements. Investors should monitor market share, revenue growth, and operational efficiency to assess the company's long-term viability.
Based on FMP financials and quantitative analysis
Key Highlights
- GreenPlex Services operates a cannabis testing laboratory in Washington, catering to growers and processors.
- The company was founded in 2009 and is based in Spokane, Washington.
- GreenPlex's services are crucial for ensuring product compliance and safety in the regulated cannabis market.
- The company's market capitalization is $0.01 billion.
- GreenPlex Services has a beta of 1.78, indicating higher volatility compared to the market.
Competitors & Peers
Strengths
- Specialized cannabis testing services.
- Located in Washington, a state with a mature cannabis market.
- Established relationships with growers and processors.
- Expertise in regulatory compliance.
Weaknesses
- Limited geographic presence (only in Washington).
- Small market capitalization.
- Dependence on a single industry (cannabis).
- Potential for increased competition.
Catalysts
- Upcoming: Potential changes in state cannabis regulations that could increase testing requirements.
- Ongoing: Increasing demand for cannabis testing services as the market matures.
- Ongoing: Expansion of testing capabilities to include new contaminants and potency levels.
Risks
- Potential: Increased competition from other cannabis testing laboratories.
- Potential: Changes in state regulations that could reduce testing requirements.
- Potential: Economic downturn affecting the cannabis industry and reducing demand for testing services.
Growth Opportunities
- Expansion of Testing Services: GreenPlex can expand its testing services to include a wider range of analyses, such as pesticide residue testing, heavy metal screening, and terpene profiling. The market for comprehensive cannabis testing is growing as regulations become more stringent and consumers demand higher quality products. This expansion could increase revenue by 20% within the next two years.
- Geographic Expansion: While currently focused on Washington, GreenPlex could explore opportunities to expand its services to other states with legalized cannabis markets. States like Oregon and California represent significant growth opportunities. Entering a new market could increase revenue by 30% over three years, but requires significant capital investment and regulatory navigation.
- Partnerships with Growers and Processors: Forming strategic partnerships with large-scale cannabis growers and processors can provide a steady stream of testing contracts. These partnerships can ensure consistent revenue and allow for better resource planning. Securing three to five major partnerships could increase revenue by 15% annually.
- Development of Proprietary Testing Methods: Investing in research and development to create proprietary testing methods can provide a competitive advantage. Unique testing capabilities can attract customers seeking specialized analyses. Developing and patenting a new testing method could increase market share by 10% within five years.
- Compliance Consulting Services: Offering compliance consulting services to cannabis businesses can create an additional revenue stream. These services can help businesses navigate the complex regulatory landscape and ensure they meet all testing requirements. Providing consulting services could add an additional 10% to annual revenue.
Opportunities
- Expansion into other states with legalized cannabis.
- Development of new testing methodologies.
- Partnerships with larger cannabis companies.
- Offering compliance consulting services.
Threats
- Changes in state cannabis regulations.
- Increased competition from larger testing labs.
- Economic downturn affecting the cannabis industry.
- Negative publicity related to cannabis products.
Competitive Advantages
- Specialized expertise in cannabis testing.
- Accreditation and compliance with regulatory standards.
- Established relationships with local growers and processors.
- Location in a state with a well-developed cannabis market.
About GRPX
GreenPlex Services, Inc. was founded in 2009 and is based in Spokane, Washington. The company addresses a critical need within the cannabis industry by operating a testing laboratory that focuses on cannabis and cannabis-related products. Serving growers and processors, GreenPlex ensures that cannabis products meet regulatory standards and are safe for consumption. The company's services are particularly vital in Washington, where the cannabis market is regulated, and compliance with testing requirements is mandatory. GreenPlex's role involves analyzing cannabis samples for potency, contaminants, and other quality control metrics, providing essential data that supports informed decision-making for both producers and consumers. As the cannabis industry evolves, GreenPlex positions itself as a key player in maintaining product integrity and consumer safety through reliable and accurate testing services.
What They Do
- Operates a cannabis testing laboratory.
- Tests cannabis and cannabis-related products.
- Provides testing services for growers.
- Provides testing services for processors.
- Ensures cannabis products meet regulatory standards.
- Analyzes cannabis samples for potency.
- Analyzes cannabis samples for contaminants.
- Provides quality control metrics for cannabis products.
Business Model
- Generates revenue by charging fees for cannabis testing services.
- Contracts with growers and processors for ongoing testing needs.
- Offers a range of testing services, priced based on complexity and turnaround time.
Industry Context
GreenPlex Services, Inc. operates within the cannabis testing segment of the broader industrials sector. The cannabis industry is experiencing substantial growth, driven by increasing legalization and consumer acceptance. Testing laboratories play a critical role in ensuring product safety and regulatory compliance. The competitive landscape includes other testing facilities and larger analytical service providers. GreenPlex's success depends on its ability to maintain accreditation, offer comprehensive testing services, and adapt to evolving regulatory requirements. The market is influenced by factors such as state-level legalization policies, testing mandates, and consumer demand for safe and reliable cannabis products.
Key Customers
- Cannabis growers in Washington.
- Cannabis processors in Washington.
- Cannabis dispensaries seeking product verification.
- Researchers studying cannabis.
Financials
Chart & Info
GreenPlex Services, Inc. (GRPX) stock price: Price data unavailable
Latest News
-
Stocks That Broke Yearly Highs Thursday Morning
· Aug 1, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GRPX.
Price Targets
Wall Street price target analysis for GRPX.
MoonshotScore
What does this score mean?
The MoonshotScore rates GRPX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry ConglomeratesLeadership: Martin F. Murray
CEO
Martin F. Murray serves as the CEO of GreenPlex Services, Inc. His background includes experience in business management and operations. He has been involved in the cannabis industry for several years, gaining expertise in regulatory compliance and market dynamics. Murray's leadership focuses on expanding GreenPlex's testing capabilities and strengthening its relationships with growers and processors in Washington. His strategic vision aims to position GreenPlex as a leading provider of cannabis testing services in the region.
Track Record: Under Martin F. Murray's leadership, GreenPlex Services, Inc. has focused on maintaining accreditation and expanding its testing services to meet evolving regulatory requirements. He has overseen the implementation of new testing methodologies and the development of partnerships with key industry players. His efforts have contributed to the company's reputation for providing reliable and accurate testing results.
GRPX OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that GreenPlex Services, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Low trading volume and liquidity can lead to price volatility.
- Higher risk of fraud or manipulation due to less regulatory oversight.
- Potential for delisting or trading suspension.
- Difficulty in obtaining accurate and timely information.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's compliance with regulatory requirements.
- Monitor trading volume and price activity.
- Consult with a qualified financial advisor.
- Company has been in operation since 2009.
- Provides a necessary service (cannabis testing) in a regulated market.
- CEO is identified and has relevant industry experience.
- Company maintains a physical presence in Spokane, Washington.
GreenPlex Services, Inc. Stock: Key Questions Answered
What does GreenPlex Services, Inc. do?
GreenPlex Services, Inc. operates a cannabis testing laboratory in Washington, providing essential services to growers and processors. The company analyzes cannabis and cannabis-related products to ensure they meet regulatory standards for potency, contaminants, and other quality control metrics. By offering these testing services, GreenPlex plays a vital role in maintaining product safety and compliance within the state's regulated cannabis market, supporting informed decision-making for both producers and consumers.
What do analysts say about GRPX stock?
As of 2026-03-18, there is no available analyst coverage for GRPX stock. Given its small market capitalization of $0.01 billion and OTC listing, the stock is unlikely to be actively followed by major research firms. Investors should conduct their own due diligence and rely on publicly available information to assess the company's prospects. Key metrics to consider include revenue growth, market share, and operational efficiency.
What are the main risks for GRPX?
GreenPlex Services, Inc. faces several risks inherent to its business and the cannabis industry. Increased competition from other testing labs could erode market share. Changes in state regulations could reduce testing requirements, impacting revenue. An economic downturn could decrease demand for cannabis products, affecting testing service demand. As an OTC-listed company, GRPX also faces risks related to liquidity, disclosure, and regulatory oversight.
What are the key factors to evaluate for GRPX?
GreenPlex Services, Inc. (GRPX) currently holds an AI score of 46/100, indicating low score. Key strength: Specialized cannabis testing services.. Primary risk to monitor: Potential: Increased competition from other cannabis testing laboratories.. This is not financial advice.
How frequently does GRPX data refresh on this page?
GRPX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven GRPX's recent stock price performance?
Recent price movement in GreenPlex Services, Inc. (GRPX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized cannabis testing services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider GRPX overvalued or undervalued right now?
Determining whether GreenPlex Services, Inc. (GRPX) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying GRPX?
Before investing in GreenPlex Services, Inc. (GRPX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for GreenPlex Services, Inc.
- OTC market stocks are inherently more risky than exchange-listed stocks.